|
|
Other links at Articles > HIV/AIDS |
| 1. |
Episodic ART Increases Long-Term Risk of Opportunistic Infections and Death
|
|
|
The risk of HIV-related infections and death remains elevated for at least 18 months after patients resume antiretroviral therapy (ART) following a planned treatment interruption, results of the multinational SMART (Strategies for Management of Anti-Retroviral Therapy) study indicate. Reuters Health Information
|
| 3. |
Anti-CCR5 Monoclonal Antibody Has Strong Anti-HIV Activity
|
|
|
Treatment with a single dose of PRO 140, a monoclonal antibody targeting the CCR5 chemokine receptor, provides potent and prolonged antiviral activity in HIV-infected adults, according to a report in The Journal of Infectious Diseases for November 1. Reuters Health Information
|
|
|